Navigation Links
Protein Thought to Promote Cancer Does Opposite
Date:7/12/2008

Study finds it functions as a tumor suppressor instead

FRIDAY, July 11 (HealthDay News) -- A protein that appears to suppress the growth of human cancer cells in lab cultures was, until recently, thought to promote colorectal cancer.

Previous animal studies have found that a gene called TCF7L2 is active in about 90 percent of colorectal cancers because of a biochemical malfunction in a gene. As a result, researchers suspected TCF7L2 triggered colorectal cancer in humans.

New technology used by University of Texas Southwestern Medical Center at Dallas researchers, however, allowed them to study the gene on human colorectal cancer cells. When the researchers switched off the TCF7L2 gene, human colorectal cancer cells actually grew stronger and more rapidly in lab cultures.

"This finding reshapes a fundamental model of how colorectal cancer arises," senior study author Lawrence Lum, an assistant professor of cell biology at UT Southwestern, said in a university news release.

The study was published online in this week's issue of the Proceedings of the National Academy of Sciences.

The next step, he said, is to understand more fully all the steps in the biochemical pathway involved in controlling the action of TCF7L2. This may help find new therapeutic targets for treating colorectal cancer.

More information

The American Cancer Society has more about colorectal cancer.



-- Kevin McKeever



SOURCE: University of Texas Southwestern Medical Center at Dallas, news release, July 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Pressured proteins: A little pressure in proteomics squeezes 4-hour step into a minute
2. Discovery of key malaria proteins could mean sticky end for parasite
3. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
4. Protein thought to promote cancer instead functions as a tumor suppressor
5. Zinc finger proteins put personalized HIV therapy within reach
6. DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins
7. Gene silencer and quantum dots reduce protein production to a whisper
8. Could new discovery about a shape-shifting protein lead to a mighty morpheein bacteria fighter?
9. Alzheimers Protein Tied to HIV Progression
10. Is it time to revisit the current protein recommendations?
11. Lou Gehrigs protein found throughout brain, suggesting effects beyond motor neurons
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein Thought to Promote Cancer Does Opposite
(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... people suffering from acne, access to quality care can be limited while the desire ... company that offers customized prescription acne care for every customer online, today released its ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive porcelain ... smile.” The National Association of Dental Laboratories (NADL) is informing dentists about the ... of when utilizing dental laboratories and technicians that create these veneers. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, Patten ... , The seed processing plant opened in Marshallville in 2006, and a bagging and ... allows opportunity for transition of Patten Seed operations to the Middle Georgia location from ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... replace their missing teeth can now have them placed by Dr. Manju Kejriwal, with ... i-CAT® Cone Beam technology to increase the accuracy of each dental implant placement. The ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
Breaking Medicine Technology: